Agilent SureFISH probes deliver
dramatically better performance compared to existing FISH products. SureFISH
probes enable users to specifically detect aberrations in regions of the genome
as small as 50kb, as well as aberrations near highly repetitive regions. They
provide higher resolution and faster hybridization times than competing
technologies and are designed to enable users to meet American College of
Medical Genetics guidelines for clinical cytogenetics.
"Based on our experience with
Agilent high-resolution oligo FISH, it is apparent the oligo design methodology
for SureFISH will be a powerful tool for analysis of previously difficult
genomic regions," said early access user Shashikant Kulkarni, M.S., Ph.D.,
FACMG, head of Clinical Genomics and medical director, Cytogenomics and
Molecular Pathology, Washington University School of Medicine at St. Louis.
Manufactured at Agilent's Cedar Creek,
Texas, facility, which is registered with the U.S. Food and Drug Administration
as a medical device establishment, Agilent SureFISH probes are Class I Analyte
Specific Reagents. They are manufactured under Quality Standard Regulations and
current Good Manufacturing Practices.
"We're making a major impact in
the cytogenetics community with a comprehensive portfolio of high-performance
products that enable cytogenetic researchers to choose a molecular analysis
method that best fits their needs," said Robert Schueren, Agilent vice
president and general manager, Genomics. "Our comprehensive cytogenetics
portfolio includes SureFISH probes, CGH and CGH+SNP arrays, scanner and Agilent
CytoGenomics software. Customers now have a single source for all their
cytogenetics needs."
Agilent offers an extensive menu of
FISH probes for constitutional and cancer applications. The initial menu
includes hundreds of SureFISH probes for the most common regions, to
accommodate a wide range of cytogenetic research needs. Agilent plans to
introduce additional SureFISH probes later this year. Customers can easily
select SureFISH probes at the new SureFISH website: www.agilent.com/genomics/SureFISH.
The SureFISH chromosome browser facilitates probe selection and online
purchase. The site also includes images of all probes hybridized at four and 14
hours, allowing users to see the probe performance prior to purchase.
For more information about Agilent
SureFISH probes, visit www.agilent.com/genomics/SureFISH.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is
the world's premier measurement company and a technology leader in chemical
analysis, life sciences, electronics and communications. The company's 18,700
employees serve customers in more than 100 countries. Agilent had net revenues
of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.